MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$23,577
Unit: Dollar
Positive Cash Flow Breakdown
Accounts payable
Accrued interest - related parti...
Accrued expenses and other liabi...
Others
Negative Cash Flow Breakdown
Accounts payable - related parti...
Write-off of accrued liabilities
Note and loan payments
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-26,415
-1,017,805
-80,565
-445,199
Depreciation and amortization
12,943
12,945
12,376
49,754
Amortization of debt discounts
0
0
1,976
319
Fair value of common shares issued to officers and directors for services
6,782
0
0
0
Impairment
-
725,000
-
-
Fair value of common shares issued for services
23,571
126,712
80,915
173,106
Fair value of common shares issued as loan incentives
0
975
0
5,900
Interest capitalized to debt balance
3,944
4,035
4,033
6,759
Fair value of warrants issued for refunds
-
0
0
-
Write-off of accrued liabilities
81,334
-
-
-
Accounts receivable
-21,335
-22,892
41,495
6,123
Inventories
-14,125
-2,447
-24,852
23,136
Prepaid expenses and other assets
914
-18,986
6,446
-75,533
Accounts payable
82,984
156,339
-109,148
141,321
Accounts payable - related parties
-98,499
-38,025
61,399
110,585
Accrued expenses and other liabilities
33,718
53,771
-24,896
-47,465
Accrued interest - related parties
38,088
36,911
34,835
71,399
Deferred revenue
-3,699
-35,547
-29,400
-71,853
Net cash provided by operating activities
26,629
69,636
-71,564
40,900
Purchases of property and equipment
-
3,057
6,000
0
Purchases of intangibles
-
0
0
50,000
Cash acquired in docsun transaction
-
0
0
0
Net cash used in investing activities
-
-3,057
-6,000
-50,000
Note and loan payments
56,017
44,142
46,674
23,592
Increase in note and loan balances - related parties
-
0
0
0
Increase in note and loan balances
5,811
-1
117,507
30,000
Net cash used in financing activities
-50,206
-44,143
70,833
6,408
Net effect of exchange rate fluctuations
0
0
7,222
-9,256
Net increase/(decrease) in cash and cash equivalents
-23,577
22,436
491
-11,948
Cash and cash equivalents, beginning balance
69,383
46,947
58,404
-
Cash and cash equivalents, ending balance
45,806
69,383
46,947
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts payable
$82,984
Accrued interest -
related parties
$38,088
Accrued expenses and
other liabilities
$33,718
Fair value of common
shares issued for...
$23,571
Accounts receivable
-$21,335
Inventories
-$14,125
Depreciation and
amortization
$12,943
Fair value of common
shares issued to...
$6,782
Interest capitalized to
debt balance
$3,944
Net cash provided by
operating activities
$26,629
Canceled cashflow
$210,861
Net
increase/(decrease) in cash and cash...
-$23,577
Canceled cashflow
$26,629
Increase in note and loan
balances
$5,811
Accounts payable -
related parties
-$98,499
Write-off of accrued
liabilities
$81,334
Net loss
-$26,415
Deferred revenue
-$3,699
Prepaid expenses and
other assets
$914
Net cash used in
financing activities
-$50,206
Canceled cashflow
$5,811
Note and loan
payments
$56,017
Buy us a coffee
BIOREGENX, INC. (BRGX)
BIOREGENX, INC. (BRGX)